alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › metformin

metformin

2 studies tagged metformin, dated 2021-09-01 to 2022-07-29. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study 2022-07-29
  2. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment 2021-09-01

Studies

2 studies carry this tag.

Date range

2021 to 2022

Top journals

  • Diabetologia 1
  • Pharmaceuticals (Basel, Switzerland) 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Diabetologia 2022-07-29 Genetics

    Metformin use may cause reduced Alzheimer's disease risk in the general population.

  2. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Pharmaceuticals (Basel, Switzerland) 2021-09-01 Drug development

    Alzheimer's disease (AD) is one of the most devastating brain disorders.

All topic tags with their study counts